Phase IB 9CUAB30 in early stage breast cancer to evaluate biologic effect

Ended Awarded Last action

Contract number
HHSN26100009
Awardee
Awarding agency
Obligated
$566,601

Award facts

Opportunity
Contract value 86% obligated
  • $566,600.62 Current, with exercised options
  • $655,319.62 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 8 offers Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Madison, WI 53715, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00009 -$184,767
Change Order P00008 $0
Change Order P00007 $0
Funding Only Action P00006 -$208,638
Change Order P00005 $0
Change Order P00004 $15,067
Exercise an Option P00003 $271,856
Other Administrative Action P00002 $0
Other Administrative Action 1 -$19,254
Original award $692,337

About this award

This $655,319.62 federal contract was awarded by the National Cancer Institute, which is part of the U.S. Department of Health and Human Services, to the University of Wisconsin System's division at the University of Wisconsin - Madison. The contract is for a Phase 1B clinical study to evaluate the biological effect of an early-stage breast cancer prevention agent. This award is part of the Cancer Prevention Agent Development Program, which supports early-phase clinical research. The contract has no set-aside designation and is a cost-reimbursement type, with an ultimate completion date of September 22, 2023.

Quick answers

Who was awarded contract HHSN26100009?

HHSN26100009 was awarded to University Of Wisconsin System by National Cancer Institute (National Institutes of Health) on August 12, 2016.

How much is contract HHSN26100009 worth?

The government has obligated $566,601 on HHSN26100009. Its potential value, with all options, is $655,320.

Is contract HHSN26100009 an order under another contract?

Yes. HHSN26100009 is a delivery order under HHSN261201200033I, an indefinite delivery contract, on Cancer Prevention Agent Development Program 2012-2017.

Was contract HHSN26100009 competed?

The extent of competition for HHSN26100009 was full and open competition. The government received 8 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award